Screener
Twist Bioscience Corporation TWST Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherLongTermDebt.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | March 31,2026 | September 30,2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 67,848 | 35,202 |
| Total current liabilities | $119,976 | $91,406 |
| Operating lease liability, net of current portion | 85,398 | 61,750 |
| Liability related to the sale of future revenue | 15,000 | 15,000 |
| Other non-current liabilities[1] | 746 | 747 |
| Total liabilities | $221,120 | $168,903 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's long-term debt?
- Twist Bioscience Corporation (TWST) reported long-term debt of $15M in Q1 2026.
- How has Twist Bioscience Corporation's long-term debt changed year-over-year?
- Twist Bioscience Corporation's long-term debt decreased by 0.0% year-over-year, from $15M to $15M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Twist Bioscience Corporation's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude